Iams Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4,850
Closed -$1.2M – 193
2026
Q2
$1.2M Buy
4,850
+59
+1% +$12.7K 0.36% 85
2026
Q1
$962K Buy
4,791
+144
+3% +$29.8K 0.34% 91
2025
Q4
$960K Sell
4,647
-1,081
-19% -$216K 0.35% 90
2025
Q3
$1.03M Sell
5,728
-169
-3% -$28.8K 0.41% 74
2025
Q2
$951K Buy
5,897
+596
+11% +$94.9K 0.44% 69
2025
Q1
$902K Buy
5,301
+223
+4% +$38.7K 0.41% 74
2024
Q4
$844K Buy
5,078
+432
+9% +$73.8K 0.39% 73
2024
Q3
$799K Buy
+4,646
New +$769K 0.39% 74

Other funds holding FBT

Iams Wealth Management's FBT Position: Q3 2026 in Review

Iams Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 4,850 shares — an estimated $1.2M sold.

Iams Wealth Management first reported a position in FBT in Q3 2024 and held it in 8 quarters. The position peaked at $1.2M in Q2 2026. 350 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Iams Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
  • Iams Wealth Management sold 4,850 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $1.2M.
  • Iams Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and held it in 8 quarters.
  • Iams Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.2M in Q2 2026.
  • 350 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Iams Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.